Top

Calcified Tissue International

Content (16 Articles)

Parathyroid Hormone Secretory Response to EDTA-Induced Hypocalcemia in Black and White Premenopausal Women

F. Cosman, J. Nieves, D. Morgan, V. Shen, D. Sherwood, M. Parisien, R. Lindsay

Vitamin D Binding Protein Gene in Male Osteoporosis: Association of Plasma DBP and Bone Mineral Density with (TAAA)n-Alu Polymorphism in DBP

S. S. Papiha, L. C. Allcroft, R. M. Kanan, R. M. Francis, H. K. Datta

Prednisolone Induces an Increase in Serum Calcium Concentration: Possible Involvement of the Kidney, the Bone, and the Intestine

K. Yonemura, A. Hishida, M. Kimura, T. Watanabe, H. Kumagai

Effects of Promethazine on Bone Mass and on Bone Remodeling in Ovariectomized Rats: A Morphometric, Densitometric, and Histomorphometric Experimental Study

H. Rico, M. Gómez, M. Revilla, J. González-Riola, C. Seco, E. R. Hernández, L. F. Villa, J. J. Gervás

Inhibition of Chondrocyte Terminal Differentiation and Matrix Calcification by Soluble Factors Released by Articular Chondrocytes

A. Jikko, Y. Kato, H. Hiranuma, H. Fuchihata

Computer-Assisted 3D Reconstruction of Serial Sections of Cortical Bone to Determine the 3D Structure of Osteons

S. D. Stout, B. S. Brunsden, C. F. Hildebolt, P. K. Commean, K. E. Smith, N. C. Tappen

The Effect of Vitamin K and D Supplementation on Ovariectomy-Induced Bone Loss

S. Matsunaga, H. Ito, T. Sakou

Editorial

Vitamin D and the D-Hormones, Alfacalcidol and Calcitriol, as Therapeutic Agents for Osteoporotic Populations

L. V. Avioli

Vitamin D Therapy of Osteoporosis: Plain Vitamin D Therapy Versus Active Vitamin D Analog (D-Hormone) Therapy

K.-H. W. Lau, D. J. Baylink

The Special Role of ``Hormonal'' Forms of Vitamin D in the Treatment of Osteoporosis

B. E. C. Nordin, A. G. Need, H. A. Morris, M. Horowitz

The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis

A. Shiraishi, S. Higashi, H. Ohkawa, N. Kubodera, T. Hirasawa, I. Ezawa, K. Ikeda, E. Ogata

Rationale for Treatment of Involutional Osteoporosis in Women and for Prevention and Treatment of Corticosteroid-Induced Osteoporosis with Alfacalcidol

E. Schacht

Alphacalcidol in Prevention of Glucocorticoid-Induced Osteoporosis

J. Y. Reginster, C. de Froidmont, M.-P. Lecart, N. Sarlet, J.-O. Defraigne

Calcium and Vitamin D Therapy in Corticosteroid-Induced Bone Loss: What is the Evidence?

J. D. Adachi, G. Ioannidis

Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium

J. D. Ringe, A. Cöster, T. Meng, E. Schacht, R. Umbach

Alfacalcidol and Calcitriol in the Prevention of Bone Loss after Organ Transplantation

P. Sambrook

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.